132
Views
13
CrossRef citations to date
0
Altmetric
Clinical Focus: Neurological and Neuropsychiatric Disorders

Bipolar Disorder: An Update

, MD, , MD, , MD, , MD & , MD
Pages 24-31 | Published online: 13 Mar 2015

References

  • . Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D. Costs of bipolar disorder. Pharmacoeconomics. 2003;21(9):601–622
  • . Morselli PL, Elgie R, Cesana BM. GAMIAN-Europe/BEAM survey II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style. Bipolar Disord. 2004;6(6):487–497
  • . Angst J, Marneros A. Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord. 2001;67(1–3):3–19
  • . Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 2000;48(6):445–457
  • . Hare E. The two manias: a study of the evolution of the modern concept of mania. Br J Psychiatry. 1981;138:89–99
  • . Spitzer RL, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35(6):773–782
  • . American Psychiatric Association. DSM-5 Development. 2010. http://www.dsm5.org/Pages/Default.aspx. Accessed July 7, 2009
  • . American Psychiatric Association. Diagnostic and Statistics Manual, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Press; 2000
  • . Judd LL, Akiskal HS, Schettler PJ,. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;(60):261–269
  • . Judd LL, Akiskal HS, Schettler PJ,. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530–537
  • . Manning JS, Zylstra RG, Connor PD. Teaching family physicians about mood disorders: a procedure suite for behavioral medicine. Prim Care Companion J Clin Psychiatry. 1999;1:18–23
  • . Curidium. 2009. http://www.curidium.com. Accessed July 7, 2009
  • . Psynomics. http://www.psynomics.com/. Accessed July 7, 2009
  • . RedOrbit. At-home test for bipolar disorder causes concern. 2008. http://www.redorbit.com/news/health/1307756/athome_test_for_bipolar_disorder_causes_concern/. Accessed July 7, 2009
  • . Gene News. Psychiatric disorders detected using blood test. 2005. http://www.genenews.com/node/111. Accessed July 7, 2009
  • . Thiruvengadam AP, Chandrasekaran K. Evaluating the validity of blood-based membrane potential changes for the identification of bipolar disorder I. J Affect Disord. 2007;100(1–3):75–82
  • . Hirschfeld RM, Williams JB, Spitzer RL,. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–1875
  • . Hirschfeld RM, Calabrese JR, Weissman MM,. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64(1):53–59
  • . Suresh KS, Roberts RJ, El-Mallakh RS. The Mood Disorders Questionnaire in an Acute Inpatient Setting. Presented at: 7th International Conference on Bipolar Disorder; June 7–9, 2007; Pittsburgh, PA
  • . Regier DA, Farmer ME, Rae DS,. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511–2518
  • . Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50(2–3):143–151
  • . El-Mallakh RS, Weisler RH, Townsend MH, Ginsberg LD. Bipolar II disorder: current and future treatment options. Ann Clin Psychiatry. 2006;18(4):259–266
  • . Calabrese JR, Vieta E, El-Mallakh R,. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry. 2004;56(12):957–963
  • . Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry. 1999;60( suppl 2):77–84
  • . Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord. 2008;107:23–28
  • . Surja AAS, Tamas RL, El-Mallakh RS. Antipsychotic medications in the treatment of bipolar disorder. Curr Drug Targets. 2006;7(9):1217–1224
  • . Tohen M, Bowden CL, Smulevich AB,. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry. 2008;192(2):135–143
  • . Sachs GS, Nierenberg AA, Calabrese JR,. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711–1722
  • . Nemeroff CB, Evans DL, Gyulai L,. A double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001;158(6):906–912
  • . Post RM, Leverich GS, Nolen WA,; Stanley Foundation Bipolar Network. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 2003;5(6):396–406
  • . Ghaemi SN, Ostacher MM, El-Mallakh RS,. A randomized clinical trial of long-term effectiveness and safety of modern antidepressants combined with mood-stabilizers. J Clin Psychiatry. In press
  • . El-Mallakh RS, Karippot A. Chronic depression in bipolar disorder. Am J Psychiatry. 2006;163(7):1137–1341
  • . El-Mallakh RS, Karippot A. Antidepressant-associated chronic irritable dysphoria (ACID) in bipolar disorder: a case series. J Affect Disord. 2005;84(2–3):267–272
  • . Mundo E, Walker M, Cate T, Macciardi F, Kennedy J. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. Arch Gen Psychiatry. 2001;58(6):539–544
  • . Rousseva A, Henry C, van den Bulke D,. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J. 2003;3(2):101–104
  • . Masoliver E, Menoyo A, Pérez V,. Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder. Psychiatric Genet. 2006;16:25–29
  • . Suppes T, Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord. 2010;121(1–2):106–115
  • . Jensen NH, Rodriguiz RM, Caron MG, Wetsel WC, Rothman RB, Roth BL. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology. 2008;33(10):2303–2312
  • . Bauer M, Pretorius HW, Constant EL, Earley WR, Szamosi J, Brecher M. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. J Clin Psychiatry. 2009;70(4):540–549
  • . Suppes T, Vieta E, Liu S, Brecher M, Paulsson B; Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry. 2009;166(4):476–488
  • . Tohen M, Vieta E, Calabrese J,. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60(11):1079–1088
  • . Corya SA, Perlis RH, Keck PE Jr,. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. J Clin Psychiatry. 2006;67(5):798–806
  • . Brown E, Dunner DL, McElroy SL,. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. Int J Neuropsychopharmacol. 2009;12(6):773–782
  • . Thase ME, Jonas A, Khan A,. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized placebo-controlled studies. J Clin Psychopharmacol. 2008;28(1):13–20
  • . Tohen M, Vieta E, Calabrese J,. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60(11):1079–1088
  • . Quante A, Zeugmann S, Luborzewski A,. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Hum Psychopharmacol Clin Exp. 2010;25(2):126–132
  • . Goodwin GM, Bowden CL, Calabrese JR,. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004;65(3):432–441
  • . Sachs GS, Lafer B, Stoll AL,. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994;55(9):391–393
  • . Gao K, Kemp DE, Ganocy SJ,. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disord. 2008;10(8):907–915
  • . Tohen M, Greil W, Calabrese JR,. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month randomized, double-blind, controlled clinical trial. Am J Psychiatry. 2005;162(7):1281–1290
  • . Vieta E, Pacchiarotti I, Valenti M, Berk L, Scott J, Colom F. A critical update on psychological interventions for bipolar disorders. Curr Psychiatry Rep. 2009;11(6):494–502
  • . Miklowitz DJ, Otto MW, Frank E,. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry. 2007;164(9):1340–1347
  • . Luby J, Belden A. Defining and validating bipolar disorder in the preschool period. Dev Psychopathol. 2006;18(4):971–988
  • . Carlson G. Bipolar disorder in children and adolescents: a critical review. In: Shaffer D, Waslick B, eds. The Many Faces of Depression in Children and Adolescents. 2002;2(1):102–127
  • . Frazier JA, Chiu S, Breeze JL,. Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry. 2005;162(7):1256–1265
  • . Vita A, De Peri L, Sacchetti E. Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord. 2009;11(8):807–814
  • . Althoff RR, Rettew C, Faraone SV, Boomsma DI, Hudziak JJ. Latent class analysis shows strong heritability of the child behavior checklist-juvenile bipolar phenotype. Biol Psychiatry. 2006;60(9):903–911
  • . Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007;64(9):1032–1039
  • . Birmaher B, Axelson D, Strober M,. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63(2):175–183
  • . Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adoles Psychiatry. 1997;36(9):1168–1176
  • . Singh MK, Delbello MP, Kowatch RA, Strakowski SM. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disord. 2006;8(6):710–720
  • . Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M; Child Psychiatric Workgroup on Bipolar Disorder. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):213–235
  • . Geller B, Tillman R, Bolhofner K, Zimerman B. Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord. 2010;12(2):164–171
  • . Henin A, Mick E, Biederman J, Fried R,. Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth? J Clin Psychiatry. 2009;70(8):1178–1185
  • . McClellen J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Pschiatry. 2007;46(1):107–125
  • . McElroy SL, Kotwal R, Kaneria R, Keck PE Jr. Antidepressants and suicidal behavior in bipolar disorder. Bipolar Disord. 2006;8(5 pt 2):596–617
  • . Miklowitz DJ, Axelson DA, Birmaher B,. Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry. 2008;65(9):1053–1061
  • . Geller B, Zimerman B, Williams M,. Six-month stability and outcome of a prepubertal and early adolescent bipolar disorder phenotype. J Child Adolesc Psychopharmacol. 2000;10(3):165–173

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.